Skip to main content

Advertisement

SpringerLink
Log in

Soluble Tumor Necrosis Factor Like Weak Inducer of Apoptosis and Vitamin D in Hemodialysis Patients: Relation to Carotid Intima-Media Thickness

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Cardiovascular disease, as the leading cause of patient death with chronic kidney disease, could be predicted by carotid atherosclerosis. The aim of the present study was to evaluate a possible relationship between serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Vitamin D levels with mean right/left carotid intima-media thickness (cIMT), in the hemodialysis (HD) patients. In this cross-sectional study, serums were obtained from 50 stable chronic HD patients and 39 healthy controls. The serum levels of sTWEAK, Vitamin D, intact parathyroid hormone (iPTH) in both groups, and cIMT were determined in HD patients by standard methods. Serum levels of sTWEAK were higher [808.8 (521.6–5032.4) pg/ml vs. 664.4 (487.4–2955.8) pg/ml (p = 0.006)] and Vitamin D levels were lower [13.4 (2.5–153) ng/ml vs. 27.8 (18.4–59.0) ng/ml (p = 0.001)] in the hemodialysis patients than in the healthy control. No important correlation was found between sTWEAK Vitamin D levels (r = 0.010/p = 0.946), and mean right(r = −0.194/p = 0.178) and left (r = 0.061/p = 0.673) cIMT in the HD patients. Our study shows that sTWEAK levels are elevated in HD patients. This elevation has no association with the cIMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Karohl C, Raggi P. Approach to cardiovascular disease prevention in patients with chronic kidney disease. Curr Treat Options Cardiovasc Med. 2012;14(4):391–413.

    Article  PubMed  Google Scholar 

  2. Liu M, Li X, Lu L, Cao Y, Sun R, Chen S, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19):2918–26.

    PubMed  CAS  Google Scholar 

  3. Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int. 2002;62(5):1791–8.

    Article  PubMed  Google Scholar 

  4. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87.

    PubMed  PubMed Central  CAS  Google Scholar 

  5. Winkles JA. The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov. 2008;7(5):411–25.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Du M, Liang Z, Xu X, Li J, Ai H, Zhang J, et al. Molecular cloning, phylogenetic analysis, tissue distribution, and expression of the cytokine TWEAK in zebrafish (Danio rerio). Biochem Genet. 2012;50(3):318–24.

    Article  PubMed  CAS  Google Scholar 

  7. Sanz AB, Izquierdo MC, Sanchez-Niño MD, Ucero AC, Egido J, Ruiz-Ortega M, et al. TWEAK and the progression of renal disease: clinical translation. Nephrol Dial Transplant. 2014;29(suppl 1):i54–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Blanco-Colio LM. TWEAK/Fn14 axis: a promising target for the treatment of cardiovascular diseases. 2. 2014.

  9. Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, et al. Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol. 2009;29(12):2061–8.

    Article  PubMed  CAS  Google Scholar 

  10. Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013;128(23):2517–31.

    Article  PubMed  Google Scholar 

  11. Drechsler C, Pilz S, Obermayer-Pietsch B, Verduijn M, Tomaschitz A, Krane V, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J. 2010;31(18):2253–61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Zheng J-Q, Hou Y-C, Zheng C-M, Lu C-L, Liu W-C, Wu C-C, et al. Cholecalciferol additively reduces serum parathyroid hormone and increases vitamin D and cathelicidin levels in paricalcitol-treated secondary hyperparathyroid hemodialysis patients. Nutrients. 2016;8(11):708.

    Article  PubMed Central  CAS  Google Scholar 

  13. Rashtchizadeh N, Ghorbanihaghjo A, Argani H, Mahmoudi Meimand S, Safa J, Vatankhahan H, et al. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. Ther Apher Dial. 2012;16(6):600–4.

    Article  PubMed  CAS  Google Scholar 

  14. Hawley CM, Holt SG. Parathyroid hormone targets in chronic kidney disease and managing severe hyperparathyroidism. Nephrology. 2017;22(S2):47–50.

    Article  PubMed  CAS  Google Scholar 

  15. Bots ML, Baldassarre D, Simon A, De Groot E, O’Leary DH, Riley W, et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J. 2007;28(4):398–406.

    Article  PubMed  Google Scholar 

  16. Dogan S, Duivenvoorden R, Grobbee DE, Kastelein JJ, Shear CL, Evans GW, et al. Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. Ann Med. 2010;42(6):447–64.

    Article  PubMed  CAS  Google Scholar 

  17. Zwiebel WJ, Pellerito JS. Introduction to vascular ultrasonography. Philadelphia: Elsevier Saunders; 2005.

    Google Scholar 

  18. Mancini GJ. Carotid intima-media thickness as a measure of vascular target organ damage. Curr Hypertens Rep. 2000;2(1):71–7.

    Article  PubMed  CAS  Google Scholar 

  19. Blanco-Colio LM, Martín-Ventura JL, Muñóz-García B, Orbe J, Páramo JA, Michel J-B, et al. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(4):916–22.

    Article  PubMed  CAS  Google Scholar 

  20. Yilmaz MI, Carrero JJ, Ortiz A, Martín-Ventura JL, Sonmez A, Saglam M, et al. Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(11):1716–23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Valdivielso JM, Coll B, Martín-Ventura JL, Moreno JA, Egido J, Fernández E, et al. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease. J Nephrol. 2013;26(6):1105–13.

    Article  PubMed  CAS  Google Scholar 

  22. Fernández-Laso V, Sastre C, Valdivielso JM, Betriu A, Fernández E, Egido J et al. Soluble TWEAK and major adverse cardiovascular events in patients with CKD. Clin J Am Soc Nephrol. 2016:CJN. 07900715.

  23. Yepes M, Brown SA, Moore EG, Smith EP, Lawrence DA, Winkles JA. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol. 2005;166(2):511–20.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Sharif MN, Campanholle G, Nagiec EE, Wang J, Syed J, O’Neil SP, et al. Soluble Fn14 is detected and elevated in mouse and human kidney disease. PLoS ONE. 2016;11(5):e0155368.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Wilhelm A, Shepherd EL, Amatucci A, Munir M, Reynolds G, Humphreys E, et al. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. J Pathol. 2016;239(1):109–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis. 2006;48(6):916–25.

    Article  PubMed  CAS  Google Scholar 

  27. Muñoz-García B, Martín-Ventura JL, Martínez E, Sánchez S, Hernández G, Ortega L, et al. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques modulation by atorvastatin. Stroke. 2006;37(8):2044–53.

    Article  PubMed  CAS  Google Scholar 

  28. Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, Lössner U, Blüher M, et al. Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis. 2008;199(2):440–4.

    Article  PubMed  CAS  Google Scholar 

  29. Yadav AK, Banerjee D, Lal A, Jha V. Vitamin D deficiency, CD4 + CD28null cells and accelerated atherosclerosis in chronic kidney disease. Nephrology. 2012;17(6):575–81.

    Article  PubMed  CAS  Google Scholar 

  30. Gracia M, Betriu À, Martínez-Alonso M, Arroyo D, Abajo M, Fernández E, et al. Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD. Clin J Am Soc Nephrol. 2016;11(2):287–96.

    Article  PubMed  CAS  Google Scholar 

  31. Ng Y-M, Lim S-K, Kang P-S, Kadir KAA. Tai M-LS. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients. BMC Nephrol. 2016;17(1):151.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Salekzamani S, Bavil AS, Mehralizadeh H, Jafarabadi MA, Ghezel A, Gargari BP. The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial. Endocrine. 2017;57(1):51–59.

  33. Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone. 2016.

Download references

Author information

Authors and Affiliations

  1. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    Farahnaz Askarian, Amir Ghorbanihaghjo, Hassan Argani, Davoud Sanajou, Ravan Ahmadi & Nadereh Rahtchizadeh

  2. Department of Radiology, Bushehr University of Medical Sciences, Bushehr, Iran

    Nima Nasehi

  3. Bushehr University of Medical Sciences, Bushehr, Iran

    Roya Askarian

Authors
  1. Farahnaz Askarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amir Ghorbanihaghjo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hassan Argani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Davoud Sanajou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nima Nasehi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roya Askarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ravan Ahmadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nadereh Rahtchizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nadereh Rahtchizadeh.

Ethics declarations

Conflict of interest

The authors declare they have no competing interests or conflicts of interest associated with this manuscript.

Ethical stadards

The ethics committee at the Tabriz University of Medical Sciences reviewed and approved the present study, in compliance with the Declaration of Helsinki.

Informed consent

Informed consent was obtained from all participants.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Askarian, F., Ghorbanihaghjo, A., Argani, H. et al. Soluble Tumor Necrosis Factor Like Weak Inducer of Apoptosis and Vitamin D in Hemodialysis Patients: Relation to Carotid Intima-Media Thickness. Ind J Clin Biochem 33, 297–303 (2018). https://doi.org/10.1007/s12291-017-0675-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-017-0675-0

Keywords

Search

Navigation